Back to Agenda
Public Expectation vs. Regulatory Complexity: Scenarios for Safe Innovation in Medical Technology
Session Chair(s)
Christopher Hodges
Professor , Head of CMS Research Programme on Civil Justice Systems
Oxford University, United Kingdom
In this session challenges and issues of the current European medical device regulatory system (such as inherent complexity, scarcity of available expertise and lack of public understanding) and lessons learnt from the pharmaceutical sector will be identified. The session will follow an interactive format, in which a panel of renowned experts together with the audience will formulate and discuss potential options and solutions.
Speaker(s)
Debater
Gert Bos, PhD, MSc
Qserve Group B.V., Netherlands
Chief Scientific Oficer, Executive Director, Partner
Debater
Robert Geertsma
RIVM, Netherlands
Senior Scientist/Project Leader
Debater
Sabina Hoekstra-van den Bosch, PharmD, MSc, RPh
Tüv Süd, Netherlands
Global Director Regulatory Strategy
Debater
Hugo Hurts
Medicines Evaluation Board (MEB), Netherlands
Chair HMA Brexit Task Force; Executive Director
Debater
Eric Klasen
Medtronic International Trading Sarl, Switzerland
Vice President, Regulatory Affairs & Quality
Debater
John Wilkinson
MHRA, United Kingdom
Director of Devices
Have an account?